Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H18NO8P |
Molecular Weight | 299.2149 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(COP(O)(O)=O)[C@@H](O)C(=O)NCCC(O)=O
InChI
InChIKey=XHFVGHPGDLDEQO-ZETCQYMHSA-N
InChI=1S/C9H18NO8P/c1-9(2,5-18-19(15,16)17)7(13)8(14)10-4-3-6(11)12/h7,13H,3-5H2,1-2H3,(H,10,14)(H,11,12)(H2,15,16,17)/t7-/m0/s1
Molecular Formula | C9H18NO8P |
Molecular Weight | 299.2149 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Phosphopantothenic acid is an amidoalkyl phosphate that is the 4-phosphate derivative of (R)-pantothenic acid. Phosphopantothenic acid is not permeable to cell membranes due to its anionic character, consistent with the observation that systemic administration of Phosphopantothenic acid does not restore CoA levels in cellular and mouse models
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Chemo- and regioselective peptide cyclization triggered by the N-terminal fatty acid chain length: the recombinant cyclase of the calcium-dependent antibiotic from Streptomyces coelicolor. | 2004 Mar 16 |
|
Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action. | 2009 Apr |
|
Kinetic characterization of human phosphopantothenoylcysteine synthetase. | 2009 Dec |
|
Characterization and kinetics of phosphopantothenoylcysteine synthetase from Enterococcus faecalis. | 2009 Mar 31 |
|
Kinetic and inhibition studies of dihydroxybenzoate-AMP ligase from Escherichia coli. | 2010 May 4 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:27:39 GMT 2023
by
admin
on
Sat Dec 16 09:27:39 GMT 2023
|
Record UNII |
1SCE5NG3E8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
427114
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5875-50-3
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
PRIMARY | |||
|
DTXSID40974271
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
PRIMARY | |||
|
1SCE5NG3E8
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
PRIMARY | |||
|
15905
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
PRIMARY | |||
|
41635
Created by
admin on Sat Dec 16 09:27:39 GMT 2023 , Edited by admin on Sat Dec 16 09:27:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |